Gastroentrology
Bisocred-2.5
Price on request/100 · MOQ 100 boxes
Bisocred-2.5 Tablets by Novalab Cardiac & Diabetic Care contain Bisoprolol Fumarate 2.5 mg, a selective beta-1 adrenergic receptor blocker prescribed for the management of certain cardiovascular conditions, including hypertension, angina pectoris and stable chronic heart failure.
Bisoprolol works by selectively blocking beta-1 adrenergic receptors in the heart. This action reduces heart rate, decreases the force of cardiac contractions and lowers the heart's oxygen demand, helping control blood pressure and reduce cardiac workload.
Bisocred-2.5 Tablets may be prescribed for adults with high blood pressure, chronic stable angina or selected cases of stable chronic heart failure. In patients with heart failure, Bisoprolol is generally used as part of a comprehensive treatment plan under careful medical supervision.
The medicine may also be prescribed for selected heart rhythm conditions when controlling heart rate is clinically appropriate.
Effective cardiovascular management may involve regular blood pressure monitoring, heart rate assessment, lifestyle modifications and adherence to prescribed treatment.
Bisocred-2.5 Tablets should be taken strictly according to a registered medical practitioner's prescription. The appropriate dosage depends on the patient's cardiovascular condition, blood pressure, heart rate, medical history and treatment response.
CategoryGastroentrology
Min. Order100 boxes
Supplied byNovalab Cardiac Diabetic Care
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Bisoprolol Fumarate Tablets
- Packaging Type
- Tablets
- Packaging Size
- —
- Dosage Form
- Tablet
- Treatment
- May be prescribed for selected patients with stable chronic heart failure as part of combination therapy.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Novalab Cardiac Diabetic CarePanchkula, Haryana
Novalab Cardiac Care (part of Novalab Group / Novalab Healthcare) is an ISO-certified, WHO-GMP approved pharmaceutical division in India that specializes in cardiac and anti-diabetic drug formulations and offers PCD (Propaganda Cum Distribution) pharma franchise opportunities.
Core Offerings & Products
• Therapeutic Range: Focuses on medicines for cardiovascular conditions, hypertension (high blood pressure), cholesterol management, heart attacks, strokes, and Type 1 and Type 2 diabetes mellitus.
• Formulations: Includes tablets, capsules, soft gels, syrups, and injectables (such as Novazdil F, Racecred 100, and Wattag Omega 3).
• Quality Standards: Products comply with ISO, WHO-GMP, DCGI, and FSSAI guidelines.
PCD Franchise & Business Model
• Monopoly Rights: Offers exclusive area-wise monopoly distribution rights to franchise partners so they face no internal brand competition in their assigned region.
• Promotional Support: Provides free promotional and marketing tools like MR bags, visual aids, visiting cards, reminder cards, and diaries.
• Business Opportunity: Designed for low-investment, high-margin local distribution across India
More Gastroentrology
